Search

everythinglearnresearchcommunity

for

Search:↓

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Sphingosine 1-phosphate and its receptor S1PR3 are key in controlling mechanical pain.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.

Sphingosine 1-phosphate helps control mechanical pain.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Phospholipids help plant proteins move by regulating receptor interactions.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Abrocitinib may effectively treat Lichen Planopilaris.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

GLABRA2 gene controls root-hair growth by regulating phospholipid signaling.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The Itpr3 gene causes a specific hair pattern in mice.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

Mrp3 helps in wound healing and hair growth.